Investigating how gut bacteria affect drug effectiveness in tuberculosis and diabetes patients
Gut Microbiome and Pharmacokinetic Variability in Tuberculosis and Diabetes
['FUNDING_OTHER'] · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · NIH-10893634
This study is looking at how the bacteria in your gut might affect how well tuberculosis medications work, especially for people with and without type 2 diabetes, to help create better, personalized treatments for everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUTGERS BIOMEDICAL AND HEALTH SCIENCES (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-10893634 on ClinicalTrials.gov |
What this research studies
This research aims to understand how the gut microbiome influences the effectiveness of tuberculosis (TB) medications in patients with and without type 2 diabetes mellitus (DM). By analyzing stool samples and drug absorption rates, the study will explore the relationship between gut bacteria diversity and drug pharmacokinetics. Patients will be involved in a prospective observational trial that examines how diabetes affects drug bioavailability and treatment outcomes in TB. The findings could lead to personalized treatment strategies for TB patients based on their gut microbiome composition.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with active tuberculosis and type 2 diabetes mellitus.
Not a fit: Patients without tuberculosis or diabetes, or those with other unrelated health conditions, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for tuberculosis patients, particularly those with diabetes, by optimizing drug therapies based on individual gut microbiome profiles.
How similar studies have performed: Other research has shown promising results in understanding the role of the gut microbiome in drug metabolism, suggesting that this approach could yield valuable insights.
Where this research is happening
Newark, UNITED STATES
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NARAYANAN, NAVANEETH — RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- Study coordinator: NARAYANAN, NAVANEETH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus